“…Like myofibroblasts, exogenous stem cells and progenitor cells (introduced by reparative/regenerative cellular or tissue therapies) express Cx43 and have more depolarized resting membrane potentials than native cardiomyocytes. For example, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have flourished as a powerful tool for drug discovery, disease modeling (Chow et al, 2013 ; Rocchetti et al, 2017 ; Chai et al, 2018 ; Wong et al, 2020 ), and regenerative medicine (Rhee and Wu, 2018 ; Sadahiro, 2019 ; Huang et al, 2020 ). However, in contrast to adult cardiomyocytes that have stable and more negative resting membrane potential (around −85 mV), hiPSC-CMs do not achieve sufficiently negative membrane potential (−40 to −70 mV), presumably due to inadequate expression of inward rectifier current I K1 (Goversen et al, 2018 ; Horváth et al, 2018 ).…”